This presentation will look at how the distribution of diabetes is, thus we’ll discuss how the distribution of diabetes are by type, gender, age, geographical region and ethnicity. The purpose of this discussion is to understand how serious a health problem the global epidemic of diabetes is, while increasing the understanding that it’s extremely necessary that we do whatever we can to fight against the diabetes epidemic in the future.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation tries to identify the most important risk factors for developing diabetes. In order to take the next steps in planning diabetes prevention, we need to know what distinguished those at risk of developing diabetes from those who aren’t or are at lower risk within the populations.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to the genetic aspects of non-autoimmune diabetes. First we’ll introduce the genetic basis of diabetes, then we’ll talk about methods to identify genetic loci associated with diabetes and pre-diabetic traits. In continuation of this, we’ll provide examples of monogenic forms of diabetes and finally we’ll discuss common forms of non-autoimmune diabetes.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to methods used to identify genetic loci affecting diabetes and pre-diabetes traits. Furthermore we’ll discuss aspects that are important when choosing and considering different methods.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

In this presentation we’ll present a genetic atlas of the non-autoimmune diabetes and describe monogenic forms of diabetes.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to the genetics behind the common forms of type 2 diabetes. Furthermore we’ll provide an introduction to the Genome-Wide Association Study, this study is a hypothesis generating method that contains a discovery and a replication sample.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentations discuss diabetes as an disease of the pancreatic beta cell, in continuation of this, we’ll discuss what causes beta cell failure in type 1 and type 2 diabetes. Furthermore we’ll discuss the innate immune system and the beta cell failure, and inflammatory mediators as therapeutic targets of type 1 and type 2 diabetes.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to the immune system and how it’s activated. In continuation of this we’ll discuss how inflammatory beta cell destruction comes about in type 1 diabetes. Furthermore we’ll discuss how beta cell failure occur in type 2 diabetes.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

In this interview with Dr. Robert Ross we discuss what a successful obesity management is and what a clinical meaningful weight loss is? Furthermore we discuss recommendations regarding physical activity for health in the general population and which strategies we should take to have people sustain physical activity in the long run.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

The aim of this lecture is to give the student a new perspective on the muscle, the largest organ in the body. Skeletal muscles are primary identified by the mechanical activity required for posture, movement and breathing, which depends on muscle fiber contractions. However skeletal muscle isn’t just a component in our locomotor system.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation focuses on the current and novel approaches used to develop drugs in the treatment of obesity. We’ll introduce the student to the physiological regulation of appetite and satiety in relation to meals, then we’ll provide an short overview of the previous and current treatment on the market for the treatment of obesity and finally we’ll describe some of the promising novel approaches pursued for future treatment.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an overview of the existing treatment available for treatment of obesity. Genetic studies have revealed that the genes contributing to development of obesity is mainly located in the brain, therefore it would be logical to tro to target the brain when pursuing drugs for the treatment of obesity. However it’s not that simple.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation focus’ on the health benefits of being physically active and describes how physical training affects energy balance and metabolic health. Furthermore we’ll discuss the potential of physical training in prevention and treatment of obesity and diabetes and finally we’ll demonstrate methods that can be used to evaluate physical fitness, body fat distribution and insulin sensitivity.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to physical activity and its influence on obesity, insulin resistance and diabetes type 2. Furthermore we’ll talk about how we can measure body fat distribution, insulin sensitivity and insulin resistance.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation talks about how it’s important to propagate the message that physical exercise has other health benefits effect than weight reduction and even if the body weight isn’t reduced by physical exercise, the body composition might change. Furthermore we’ll talk about the metabolic syndrome.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation aims to increase the students knowledge of physical inactivity and how it’s a major risk factor for developing diabetes, independent of body weight. Moreover we’ll discuss how we fight the global burden of a physical inactive lifestyle.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation talks about glucose regulation, how it’s possible to maintain a constant glucose level and physical regulation of plasma glucose. In continuation of this we’ll talk about diabetic complication, like neuropathy, retinopathy, nephropathy, chronic hyperglycemia, which can lead to myocardial infarction, stroke and amputations.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to the islet hormones effects on various target tissues. Insulin is such a hormone, and in continuation of this, we’ll talk about the insulin receptor signaling. Furthermore we’ll talk about liver cells, fat cells, Lipogenesis, Insulin dose-response curves, C-peptide, Glucagon and glucagon producing tumor.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation focus' on glucose and insulin, and how these are integrated in the intact organism, in continuation of this we’ll talk about, insulin and glucagon secretion, hepatic glucose production and plasma glucose concentrations. The purpose of this is to get an understanding of what happens in the body when you have type 2 diabetes. Furthermore we’ll talk about the possibility of developing an glucagon receptor antagonist, regarding the therapy of diabetes.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst

This presentation provides an introduction to diabetes (Type 1 and Type 2) development and how it’s a significant global burden. We’ll also discusses how stem cell based therapy can be used to treat diabetes and which advantages and disadvantages this treatments provides.

Course responsible: Associate Professor Signe Sørensen Torekov, MD Nicolai Wewer Albrechtsen & Professor Jens Juul Holst